← All news

Mounjaro and Wegovy reimbursement applications in Poland remain under negotiation

WA SourceWarszawa w Pigułce
Nov14 · Health
All of Warsaw
Warsaw
Иллюстративное фото: аптека в варшавском Служеве.. Фото: Radosław Botev / Wikimedia Commons, CC BY-SA 4.0

Poland’s AOTMiT agency issued negative recommendations on proposed public funding for the obesity drugs Mounjaro and Wegovy on June 29 and September 28, 2026, respectively. Those opinions did not, however, end the reimbursement process.

On October 29, the Economic Commission sent applications for various Wegovy doses back for renewed negotiations. The drug was also placed on the commission’s work schedule for November 9–10. This means discussions continue, but does not by itself introduce a discounted pharmacy price.

As of November 13, no final reimbursement decision had been announced for Mounjaro or Wegovy in obesity treatment. The health minister makes that decision; potential patient criteria and funding terms have not yet been established.

Read at the source
TelegramWhatsAppViberFacebookXThreads
Advertising 99.cleanwhale.pl
Comments

Loading…

No sign-up needed. Comments with links, phone numbers or abuse are checked first. Rules